David Brailer of Health Evolution sits down with Mark McClellan of the Duke-Margolis Center for Health Policy to dive deep into the next iteration of the value equation to include prescription drugs, devices and gene therapies.
David J. Brailer, MD, PhD, has served as a member of the Walgreen Co. board of directors since 2010. He is Managing Partner & CEO of Health Evolution Partners. David J. Brailer, M.D., Ph.D. is widely known as the health care industry's champion of innovation. Over the past two decades, he has shaped the evolution of health care through his work as a physician, researcher, educator, entrepreneur, policymaker and investor Full bio ›
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Duke-Margolis Center for Health Policy at Duke University with offices at Duke and in Washington DC. The new Center will support and conduct research, evaluation, implementation, and educational activities to improve health policy and health, through collaboration across Duke University and Health System, Full bio ›